申请人:Parker Hughes Institute
公开号:US20010003748A1
公开(公告)日:2001-06-14
Novel phenylethyl-thiourea (PHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of HIV.
新型苯乙基硫脲(PHET)化合物作为逆转录酶抑制剂和治疗艾滋病病毒感染的有效药物,包括艾滋病病毒的变异株、药物敏感株、耐药株和多重耐药株。